These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27485030)

  • 1. Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine.
    Gerlich WH; Glebe D
    EBioMedicine; 2016 Sep; 11():5-6. PubMed ID: 27485030
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.
    Cornelius C; Schöneweis K; Georgi F; Weber M; Niederberger V; Zieglmayer P; Niespodziana K; Trauner M; Hofer H; Urban S; Valenta R
    EBioMedicine; 2016 Sep; 11():58-67. PubMed ID: 27568223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the surface protein of hepatitis B virus.
    Zuckerman JN; Zuckerman AJ
    Antiviral Res; 2003 Oct; 60(2):75-8. PubMed ID: 14638401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.
    Mulder AM; Carragher B; Towne V; Meng Y; Wang Y; Dieter L; Potter CS; Washabaugh MW; Sitrin RD; Zhao Q
    PLoS One; 2012; 7(4):e33235. PubMed ID: 22493667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-HBs escape mutants--implication of neutralization escape and diagnostic escape].
    Okamoto H
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():98-105. PubMed ID: 15453295
    [No Abstract]   [Full Text] [Related]  

  • 7. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenic analysis of two chimeric hepatitis B core particles presenting the preS1 neutralizing epitopes].
    Su QD; Guo MZ; Yi Y; Chen SY; Jia ZY; Lu XX; Qiu F; Bi SL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):336-9. PubMed ID: 24645316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B vaccine].
    Kurokohchi K; Kuriyama S
    Nihon Rinsho; 2005 May; 63 Suppl 5():638-42. PubMed ID: 15954422
    [No Abstract]   [Full Text] [Related]  

  • 10. [HB vaccine escape mutant].
    Homma S
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():51-3. PubMed ID: 15453284
    [No Abstract]   [Full Text] [Related]  

  • 11. [The immunization effects of HBV core antigen and surface antigen fusion protein in mice].
    Li L; Tian YJ; Shen H; Zhao XP; Yang DL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):275-9. PubMed ID: 19403026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The analysis of "a" dominant mutation of hepatitis B virus in community-based population of Shandong Province, China].
    Zhang L; Yan BY; Ji F; Li MS; Song LZ; Xu AQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):424-6. PubMed ID: 21604565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy.
    Luongo M; Critelli R; Grottola A; Gitto S; Bernabucci V; Bevini M; Vecchi C; Montagnani G; Villa E
    J Clin Virol; 2015 Jan; 62():89-91. PubMed ID: 25542480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel strategies in vaccine design: can nanocapsules help prevent and treat hepatitis B?
    Gehring S; Pietrzak-Nguyen A; Fichter M; Landfester K
    Nanomedicine (Lond); 2017 Jun; 12(11):1205-1207. PubMed ID: 28517963
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study on the immune response of the therapeutic multi-epitope gene vaccine of hepatitis B virus in mice].
    Luo LM; Xia H; Liu SR; Li M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):260-2. PubMed ID: 21419043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Escape mutants of hepatitis B virus].
    Jaramillo CM; Navas MC
    Rev Chilena Infectol; 2015 Apr; 32(2):190-7. PubMed ID: 26065452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 18. Do we need better hepatitis B vaccines?
    Gerlich WH
    Indian J Med Res; 2017 Apr; 145(4):414-419. PubMed ID: 28862172
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine against human hepatitis B. 1976.
    Buynak EB; Roehm RR; Tytell AA; Bertland AU; Lampson GP; Hillerman MR
    JAMA; 1996 Dec; 276(22):1793-5. PubMed ID: 8946889
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro T cell immune responses to the preS2 antigen of the hepatitis B virus envelope protein in preS2 + S vaccine recipients. Absence of cross-reactivity of subtypes at a major T cell recognition site.
    Cupps TR; Tibbles J; Hurni WM; Miller WJ; Ellis RW; Milich D; Wetter N
    J Immunol; 1993 Sep; 151(6):3353-60. PubMed ID: 7690803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.